Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Breast Biopsy Devices Market 

5.1. COVID-19 Landscape: Breast Biopsy Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Breast Biopsy Devices Market, By Product

8.1. Breast Biopsy Devices Market, by Product, 2023-2032

8.1.1 Biopsy Needles

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Guidance Systems

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Biopsy Tables

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. Localization Wires

8.1.4.1. Market Revenue and Forecast (2021-2032)

8.1.5. Assay Kits

8.1.5.1. Market Revenue and Forecast (2021-2032)

8.1.6. Liquid Biopsy Instruments

8.1.6.1. Market Revenue and Forecast (2021-2032)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Breast Biopsy Devices Market, By Guidance

9.1. Breast Biopsy Devices Market, by Guidance, 2023-2032

9.1.1. Image-Guided Biopsy

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Mammography-guided Stereotactic Biopsy

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Mammography-guided Stereotactic Biopsy

9.1.3.1. Market Revenue and Forecast (2021-2032)

9.1.4. MRI-guided Biopsy

9.1.4.1. Market Revenue and Forecast (2021-2032)

9.1.5. Other Guidance Techniques

9.1.5.1. Market Revenue and Forecast (2021-2032)

9.1.6. Liquid Biopsy

9.1.6.1. Market Revenue and Forecast (2021-2032)

9.1.7. NGS-based Biopsy

9.1.7.1. Market Revenue and Forecast (2021-2032)

9.1.8. PCR-based Biopsy

9.1.8.1. Market Revenue and Forecast (2021-2032)

9.1.9. Microarray-based Biopsy

9.1.9.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Breast Biopsy Devices Market, By Type 

10.1. Breast Biopsy Devices Market, by Type, 2023-2032

10.1.1. Needle Breast Biopsy

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Core Needle Biopsy (CNB)

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Fine Needle Aspiration Biopsy (FNAB)

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Vacuum-assisted Biopsy (VAB)

10.1.4.1. Market Revenue and Forecast (2021-2032)

10.1.5. Open Surgical Breast Biopsy

10.1.5.1. Market Revenue and Forecast (2021-2032)

10.1.6. Excisional

10.1.6.1. Market Revenue and Forecast (2021-2032)

10.1.7. Incisional

10.1.7.1. Market Revenue and Forecast (2021-2032)

10.1.8. Liquid Breast Biopsy

10.1.8.1. Market Revenue and Forecast (2021-2032)

10.1.9. Circulating Tumor Cells

10.1.9.1. Market Revenue and Forecast (2021-2032)

10.1.10. Circulating Tumor DNA (CtDNA)

10.1.10.1. Market Revenue and Forecast (2021-2032)

10.1.11. Other Biomarkers

10.1.11.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Breast Biopsy Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.1.3. Market Revenue and Forecast, by Type (2021-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.4.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.1.4.3. Market Revenue and Forecast, by Type (2021-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.5.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.1.5.3. Market Revenue and Forecast, by Type (2021-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.2.3. Market Revenue and Forecast, by Type (2021-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.4.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.2.4.3. Market Revenue and Forecast, by Type (2021-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.5.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.2.5.3. Market Revenue and Forecast, by Type (2021-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.6.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.2.6.3. Market Revenue and Forecast, by Type (2021-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.7.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.2.7.3. Market Revenue and Forecast, by Type (2021-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.3.3. Market Revenue and Forecast, by Type (2021-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.4.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.3.4.3. Market Revenue and Forecast, by Type (2021-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.5.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.3.5.3. Market Revenue and Forecast, by Type (2021-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.6.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.3.6.3. Market Revenue and Forecast, by Type (2021-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.7.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.3.7.3. Market Revenue and Forecast, by Type (2021-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.4.3. Market Revenue and Forecast, by Type (2021-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.4.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.4.4.3. Market Revenue and Forecast, by Type (2021-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.5.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.4.5.3. Market Revenue and Forecast, by Type (2021-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.6.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.4.6.3. Market Revenue and Forecast, by Type (2021-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.7.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.4.7.3. Market Revenue and Forecast, by Type (2021-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.5.3. Market Revenue and Forecast, by Type (2021-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.4.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.5.4.3. Market Revenue and Forecast, by Type (2021-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.5.2. Market Revenue and Forecast, by Guidance (2021-2032)

11.5.5.3. Market Revenue and Forecast, by Type (2021-2032)

Chapter 12. Company Profiles

12.1. Cook Medical Incorporated

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Becton, Dickinson and Company

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Devicor Medical Products Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. C.R. Bard, Inc., Hologic Inc

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Argon Medical Devices

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Planmed OY

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Encapsule Medical Devices LLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Ethicon Endo-Surgery (Johnson and Johnson)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms